GENY:XETRA:XETRA-Amundi MSCI Millennials ESG Screened ETF Accumulation EUR (EUR)

ETF | Others |

Last Closing

USD 14.39

Change

-0.45 (-3.01)%

Market Cap

N/A

Volume

247.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.17 (-2.78%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-4.36 (-4.67%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.82 (-3.78%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.36 (-2.90%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.22 (-4.38%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.84 (-3.97%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.50 (-4.20%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.19 (-2.17%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.48 (-4.97%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.05 (+0.04%)

USD 12.26B

ETFs Containing GENY:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.31% 39% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.31% 40% F 39% F
Trailing 12 Months  
Capital Gain 4.87% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.87% 83% B 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.15% 52% F 53% F
Dividend Return 7.15% 51% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.46% 18% F 30% F
Risk Adjusted Return 34.93% 35% F 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.